Home » Topics » Regulatory » Patents

Patents
RSS

Redx Pharma introduces Wnt signaling and PORCN inhibitors

May 6, 2016

Merck & Co. presents HIF prolyl hydroxylase inhibitors

May 6, 2016

Novo Nordisk reports GLP-1 analogues

May 6, 2016

Bristol-Myers Squibb discloses PD-1/CD80 interaction inhibitors

May 6, 2016

Shenzhen University patents piscidin analogues

May 6, 2016

Rigel Pharmaceuticals announces JAK inhibitors

May 5, 2016

Mitobridge and The Salk Institute for Biological Studies patent PPARdelta receptor agonists

May 5, 2016

Sage Therapeutics discloses GABA receptor modulators

May 5, 2016

Sage Therapeutics discloses GABA receptor modulators

May 4, 2016

PHSA and University of British Columbia patent labeled compounds for cancer diagnosis

May 4, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...